D
David K. Menon
Researcher at University of Cambridge
Publications - 822
Citations - 50694
David K. Menon is an academic researcher from University of Cambridge. The author has contributed to research in topics: Traumatic brain injury & Medicine. The author has an hindex of 102, co-authored 732 publications receiving 40046 citations. Previous affiliations of David K. Menon include Hammersmith Hospital & University of Leeds.
Papers
More filters
Journal ArticleDOI
Proceedings of the Second Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness
Shraddha Mainali,Venkatesh Aiyagari,J. Alexander,Yelena G. Bodien,Varina L. Boerwinkle,Mélanie Boly,Emery N. Brown,Jeremy Brown,Jan Claassen,Brian L. Edlow,Ericka L. Fink,Joseph J. Fins,Brandon Foreman,Jennifer A. Frontera,Romergryko G. Geocadin,Joseph T. Giacino,Emily J. Gilmore,Olivia Gosseries,Flora M. Hammond,Raimund Helbok,J. Claude Hemphill,Karen Hirsch,Keri Kim,Steven Laureys,Ariane Lewis,Geoffrey Ling,Sarah Livesay,Victoria A. McCredie,Molly McNett,David K. Menon,Erika Molteni,DaiWai M. Olson,Kristine O’Phelan,Soo-Jin Park,Len Polizzotto,J. Javier Provencio,Louis Puybasset,Chethan P. Venkatasubba Rao,Courtney L. Robertson,Benjamin Rohaut,Michael Rubin,Tarek Sharshar,Lori Shutter,Gisele Sampaio Silva,W. Smith,Robert Stevens,Aurore Thibaut,Paul M. Vespa,Amy K. Wagner,Wendy C. Ziai,Elizabeth K. Zink,Jose I Suarez +51 more
TL;DR: The 2nd Curing Coma National Institutes of Health (NIH) Symposium was held from May 3 to May 5, 2019 as discussed by the authors , where the authors presented actionable research targets on the basis of the presentations and discussions at the Symposium.
Journal ArticleDOI
A randomised, double-blind, placebo-controlled crossover trial of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model: an enriched population trial.
Michael C. Lee,Simon Bond,Daniel W. Wheeler,Ingrid Scholtes,Graham Armstrong,Peter A. McNaughton,David K. Menon +6 more
TL;DR: It is concluded that ivabradine lacks analgesic effects in the capsaicin pain model at a dose that caused appreciable slowing of heart rate, and hence is unlikely to prove a useful analgesic in humans.
Journal ArticleDOI
Study of Concussion in Rugby Union through MicroRNAs (SCRUM): a study protocol of a prospective, observational cohort study.
Kamal M. Yakoub,Patrick O’Halloran,David Davies,Conor Bentley,Callum N. Watson,Mario Forcione,Ugo Scarpa,Jonathan R B Bishop,Emma Toman,Douglas Hammond,Matthew Cross,Keith Stokes,Simon Kemp,David K. Menon,Valentina Di Pietro,Antonio Belli +15 more
TL;DR: An Observational, prospective, multicentre cohort study recruiting between the 2017–2018 and 2018–2019 Rugby Union seasons to establish a panel of non-invasive MicroRNA biomarkers in urine and saliva for the rapid diagnosis of sports-related concussion and investigate the kinetics and clinical utility of these biomarker in assisting diagnostic, prognostic and return-to-play decisions.
Journal ArticleDOI
The Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Development of Case Report Forms for Global Use.
Molly McNett,Ericka L. Fink,Michelle E. Schober,Shraddha Mainali,Raimund Helbok,Courtney L. Robertson,Jorge H Mejia-Mantilla,Pedro Kurtz,Cássia Righy,Juan Diego Arroyave Roa,Carlos Villamizar-Rosales,Valeria Altamirano,Jennifer A. Frontera,Nelson Maldonado,David K. Menon,Jose I. Suarez,Sherry H.-Y. Chou +16 more
TL;DR: Specific data elements, definitions, and rationale for the adult and pediatric CDEs for Tier 1 of the GCS-NeuroCOVID consortium, as well as the translated versions adapted for use in Latin America are shared.
Journal ArticleDOI
Survival with disability. Whose life is it, anyway?
TL;DR: The RESCueicp and RESCUE-ASDH projects were funded by the National Institute for Health Research (NIHR; EME 09/800/16 and HTA 12/35/57 respectively).